KR20070091081A - Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa - Google Patents

Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa Download PDF

Info

Publication number
KR20070091081A
KR20070091081A KR1020070075434A KR20070075434A KR20070091081A KR 20070091081 A KR20070091081 A KR 20070091081A KR 1020070075434 A KR1020070075434 A KR 1020070075434A KR 20070075434 A KR20070075434 A KR 20070075434A KR 20070091081 A KR20070091081 A KR 20070091081A
Authority
KR
South Korea
Prior art keywords
csf
hgm
suspension culture
oryza sativa
ammonium sulfate
Prior art date
Application number
KR1020070075434A
Other languages
Korean (ko)
Inventor
한규범
천용강
신윤철
Original Assignee
주식회사 핸슨바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 핸슨바이오텍 filed Critical 주식회사 핸슨바이오텍
Priority to KR1020070075434A priority Critical patent/KR20070091081A/en
Publication of KR20070091081A publication Critical patent/KR20070091081A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • B01D15/327Reversed phase with hydrophobic interaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A method for isolating hGM-CSF(Human Granulocyte Microphage Colony Stimulating Factor) from suspension culture broth of Oryza sativa is provided to be able to purify the hGM-CSF with high purity by completely removing impurities such as contamination protein derived from plant and amylase from the suspension culture broth. A method for isolating hGM-CSF from suspension culture broth of Oryza sativa or a pre-treated solution thereof is characterized in that contamination protein having a similar molecular weight to that of the hGM-CSF and amylase generated by an Oryza sativa gene expression promoter system are removed by a combination of hydrophobic chromatography and ammonium sulfate, wherein the hydrophobic chromatography is phenyl sepharose.

Description

벼 세포 액체 현탁 배양액으로부터 인체 과립구 대식세포 콜로니 자극인자를 순수하게 분리 정제하는 방법 {Method for Purifying Human Granulocyte Microphage Colony Stimulating Factor from the Suspension Culture Broth of Oryza sativa}Method for Purifying Human Granulocyte Microphage Colony Stimulating Factor from the Suspension Culture Broth of Oryza sativa}

본 발명은 벼 세포 (Oryza sativa) 액체 현탁 배양액으로부터 인체 과립구 대식세포 콜로니 자극인자인 hGM-CSF를 분리 정제 시, 복잡한 당쇄의 간섭에 의해 쉽게 분리되지 않는 hGM-CSF 분자량과 그 크기가 유사한 오염단백질 뿐만 아니라 벼 세포 유전자 발현 프로모터 시스템에 의해 생성되는 아밀라제 (Amylase)를 소수성 크로마토그래피와 황산암모늄염 조합에 의해 매우 효과적으로 제거하는 방법에 관한 것으로, 본 발명에 따라 벼 세포 유래 hGM-CSF를 벼 세포 액체 현탁 배양액으로부터 순수하게 분리 정제 할 수 있다.The present invention is a rice cell ( Oryza sativa ) hGM-CSF, a human granulocyte macrophage colony stimulating factor, is isolated from liquid suspension cultures and contains a rice cell gene expression promoter as well as a contaminant protein similar in size and size to hGM-CSF that is not easily isolated by complex sugar chain interference. The present invention relates to a method for effectively removing amylase produced by the system by a combination of hydrophobic chromatography and ammonium sulfate, and according to the present invention, rice cell-derived hGM-CSF can be isolated and purified purely from rice cell liquid suspension culture. Can be.

본 발명은 벼 세포 (Oryza sativa) 액체 현탁 배양액으로부터 인체 과립구 대식세포 콜로니 자극인자인 hGM-CSF (human granulocyte macrophage colony stimulating factor)를 순수하게 분리하고 정제하는 방법에 관한 것이다.The present invention is a rice cell ( Oryza sativa ) The present invention relates to a method for purely separating and purifying human granulocyte macrophage colony stimulating factor (hGM-CSF), which is a human granulocyte macrophage colony stimulating factor.

과립구 대식세포 콜로니 자극인자 GM-CSF는 골수의 혈액세포와 혈소판의 생 성과정에 관여하며, 또한 대식세포라 분리는 백혈구의 성장을 증진시킨다. 이와 같이 GM-CSF는 조혈작용의 조절인자일 뿐만 아니라 면역세포의 생성을 증가시키는 효과 (Burgess, A. W. et al ., J. Biol , Chem . 252, 1988~2003 (1977); Metcalf, D. et al ., J. Cell Physiol . 111, 275~283 (1982)) 때문에 백혈병 환자의 골수 이식 수술 후 투여되는 약물로 쓰이며, 그 외에 재생 불량성 빈혈 등의 혈구와 관련된 질환 등에 사용된다 (Morstyn, G. et al ., TIPS 10, 154-159 (1988)). Granulocyte macrophage colony stimulator GM-CSF is involved in the production of blood cells and platelets in the bone marrow, and also the separation of macrophages promotes the growth of white blood cells. As such, GM-CSF is not only a regulator of hematopoietic activity but also increases the production of immune cells (Burgess, AW et. al ., J. Biol , Chem . 252, 1988-2003 (1977); Metcalf, D. et al ., J. Cell Physiol . 111, 275-283 (1982)), which is used as a drug to be administered after bone marrow transplantation in leukemia patients, and in addition to other diseases related to blood cells such as aplastic anemia (Morstyn, G. et. al ., TIPS 10, 154-159 (1988)).

인체 과립구 대식세포 콜로니 자극인자 hGM-CSF는 127개의 아미노산과 당쇄로 구성된 당단백질이며 당쇄화 정도에 따라 다양한 분자량을 갖는다 (Clark, S.C. et al . Int . J. Cell Clon . 6, 265~377 (1988)). 과거에는 인간 세포주 배양액 또는 오줌에서 분리 정제하였으나 유전공학기술이 발달하면서 대장균, 효모, 동식물 세포 등 다양한 숙주들로부터 인체 과립구 대식세포 콜로니 자극인자 hGM-CSF를 얻을 수 있게 되었다. 미국의 Ernst 등은 hGM-CSF 유전자를 발현시킨 후 배양액으로 분비하도록 형질전환된 효모를 증식시켜 hGM-CSF를 얻은 후 이를 ConA 친화성 크로마토그래피와 젤 여과 크로마토그래피를 통하여 분리 정제하였고 (Biotechnology 5, 831~834 (1987)), 대한민국의 이상미 등은 hGM-CSF를 분비하도록 형질 전환된 효모 배양액으로부터 1차 음이온 교환 크로마토그래피, 소수성 크로마토그래피, 2차 음이온 교환 크로마토그래피, 젤 여과 크로마토그래피 등을 거쳐 고순도로 hGM-CSF를 분리 정제하는 방법을 확립하였다 (대한민국 특허 10-0254829-0000). 한편, Zhang 등은 hGM-CSF 유전자를 발현시킨 후 Periplasm으로 분비하도록 형질 전환된 대장균을 증식시켜 hGM-CSF를 얻은 후 이를 소수성 크로마토그래피, 젤 여과 크로 마토그래피, 음이온 교환 크로마토그래피를 통하여 98%의 순도로 분리 정제하는 방법을 보고하였다 (Process Biochemistry 34, 55~58 (1999)). 이와 같이 지금까지 보고된 hGM-CSF를 순수하게 분리 정제하는 방법들은 음이온 교환수지, 소수성 크로마토그래피, 젤 여과 크로마토그래피 등을 많이 사용하는 것을 알 수 있다. Human granulocyte macrophage colony stimulator hGM-CSF is a glycoprotein consisting of 127 amino acids and sugar chains and has various molecular weights depending on the degree of glycation (Clark, SC et al . Int . J. Cell Clon . 6, 265-377 (1988)). In the past, human cell line cultures or urine were separated and purified, but the development of genetic engineering technology has been able to obtain human granulocyte macrophage colony stimulating factor hGM-CSF from a variety of hosts, such as E. coli, yeast, animal and plant cells. Ernst et al. In the United States expressed the hGM-CSF gene and expanded the yeast transformed to secrete into the culture medium to obtain hGM-CSF, which was isolated and purified by ConA affinity chromatography and gel filtration chromatography ( Biotechnology 5, 831 ~ 834 (1987)), Lee Sang-mi of Korea, etc., were subjected to primary anion exchange chromatography, hydrophobic chromatography, secondary anion exchange chromatography, gel filtration chromatography, etc. from a yeast culture medium transformed to secrete hGM-CSF. A method of separating and purifying hGM-CSF with high purity was established (Korean Patent 10-0254829-0000). Meanwhile, Zhang et al. Expressed the hGM-CSF gene and expanded E. coli transformed to secrete it into Periplasm to obtain hGM-CSF, which was then subjected to hydrophobic chromatography, gel filtration chromatography, and anion exchange chromatography. A method of separating and purifying with purity was reported ( Process Biochemistry 34, 55-58 (1999)). As such, the methods for purely separating and purifying hGM-CSF reported so far can be seen that many use anion exchange resin, hydrophobic chromatography, gel filtration chromatography, and the like.

인체 과립구 대식세포 콜로니 자극인자 hGM-CSF는 벼 세포 (Oryza sativa) 에서 발현 시 상당한 식물유래 당쇄가 비균일하게 붙게 되는데 이러한 당쇄는 hGM-CSF의 안정성과 체내 지속성을 높여주지만 정제를 용이하지 못하게 만드는 문제를 가지고 있다. 권태호 등의 보고에 따르면 벼 세포에서 발현된 hGM-CSF는 매우 비균일 하지만 모두 역가를 가지고 있으며 (Biotechnology and Bioprocess Engineering 9, 423~427 (2004)), 동 발명자들도 벼 세포 액체 현탁 배양액으로부터 hGM-CSF를 분리 정제하는 방법을 구축하는 초기부터 벼 유래 hGM-CSF의 복잡성을 인지하고 있었다. 즉, hGM-CSF에 형성된 식물유래 당쇄는 그 구조가 복잡하고 동물세포나 효모세포의 당쇄 구조와는 상당히 달라 기존의 크로마토그래피 방법들의 조건을 적용하여 벼 세포 유래 hGM-CSF를 고 순도로 정제하는 데는 상당한 어려움이 따를 것으로 예상되었다.Human granulocyte macrophage colony stimulator hGM-CSF is a rice cell ( Oryza sativa ) has significant plant-derived sugar chains that are non-uniformly attached when expressed in sativa . These sugar chains increase the stability and persistence of hGM-CSF, but have difficulty in making purification. According to Tae-ho Kwon et al., HGM-CSF expressed in rice cells is very non-uniform, but all have titers ( Biotechnology and Bioprocess Engineering 9, 423-427 (2004)), the inventors have also been aware of the complexity of rice-derived hGM-CSF from the beginning of constructing a method for separating and purifying hGM-CSF from rice cell liquid suspension culture. In other words, the plant-derived sugar chain formed in hGM-CSF has a complicated structure and is significantly different from the sugar chain structure of animal cells or yeast cells to purify rice cell-derived hGM-CSF with high purity by applying the conditions of conventional chromatography methods. It was expected that considerable difficulties would follow.

본 발명자들은 기존의 여러 연구자들이 효모, 대장균 유래 인체 과립구 대식세포 콜로니 자극인자 hGM-CSF를 고순도로 분리 정제하는데 사용한 음이온 교환 크로마토그래피, 젤 여과 크로마토그래피, 소수성 크로마토그래피를 조합 적용하여 벼 세포 유래 hGM-CSF를 고 순도로 분리 정제하는 방법을 찾고자 하였다. The present inventors have applied rice cell-derived hGM by combining anion exchange chromatography, gel filtration chromatography, and hydrophobic chromatography, which several researchers used to separate and purify human granulocyte macrophage colony stimulator hGM-CSF derived from yeast and Escherichia coli in high purity. To find a method to separate and purify -CSF with high purity.

그러나, 종래의 크로마토그래피 조건 하에서는 벼 세포 유래 hGM-CSF의 분자량과 유사한 식물유래 오염 단백질들 뿐만 아니라, 벼 세포 유전자 발현 프로모터 시스템에 의해 생성되는 아밀라제 (Amylase)가 hGM-CSF 함유 벼 세포 액체 현탁 배양액으로부터 용이하게 제거가 되지 않았다. 따라서, 이러한 불순물들을 벼 세포 액체 현탁 배양액으로부터 완전히 제거하여 벼 세포 유래 hGM-CSF를 고순도로 분리 정제하는 방법을 확립하는 것이 본 발명이 이루고자 하는 주요한 기술적 과제이다.However, under conventional chromatographic conditions, amylase produced by the rice cell gene expression promoter system, as well as plant-derived contaminating proteins similar to the molecular weight of rice cell-derived hGM-CSF, was added to hGM-CSF-containing rice cell liquid suspension cultures. It was not easily removed from. Therefore, it is a major technical task of the present invention to establish a method for separating and purifying rice cell-derived hGM-CSF with high purity by completely removing these impurities from rice cell liquid suspension culture.

본 발명자들은 이러한 기술적 과제를 해결하기 위하여 수많은 실험을 반복한 결과 기존 방법으로 제거가 어려운 오염 단백질들을 소수성 크로마토그래피 과정과 황산암모늄염을 함께 사용함으로써 hGM-CSF 용액으로부터 매우 효과적으로 제거할 수 있음을 발견하여 본 발명을 완성하게 되었다. In order to solve these technical problems, the present inventors have repeated numerous experiments and found that contaminating proteins, which are difficult to remove by the conventional method, can be effectively removed from the hGM-CSF solution by using a combination of hydrophobic chromatography and ammonium sulfate. The present invention has been completed.

이렇게 순수 분리 정제된 벼 세포 유래 hGM-CSF는 hGM-CSF 국제 표준품 및 대장균, 효모 유래의 타 hGM-CSF와 역가 비교 시 다른 반응 패턴을 보여주었으나 생물학적 활성은 매우 우수하였다.The purely purified and purified rice cell-derived hGM-CSF showed different reaction patterns when compared to the hGM-CSF international standard, and other hGM-CSF derived from E. coli and yeast, but the biological activity was excellent.

본 발명은 벼 세포 (Oryza sativa) 액체 현탁 배양액으로부터 인체 과립구 대식세포 콜로니 자극인자인 hGM-CSF를 분리 정제 시, 복잡한 당쇄의 간섭에 의해 쉽게 분리되지 않는 hGM-CSF 분자량과 그 크기가 유사한 오염단백질 뿐만 아니라 벼 세포 유전자 발현 프로모터 시스템에 의해 생성되는 아밀라제 (Amylase)를 소수성 크로마토그래피와 황산암모늄염 용출 조합에 의해 매우 효과적으로 제거하는 방법에 관한 것으로, 본 발명에 따라 벼 세포 유래 hGM-CSF를 벼 세포 액체 현탁 배양액으로부터 순수하게 분리 정제 할 수 있다. The present invention is a rice cell ( Oryza sativa ) hGM-CSF, a human granulocyte macrophage colony stimulating factor, is isolated from liquid suspension cultures and contains a rice cell gene expression promoter as well as a contaminant protein similar in size and size to hGM-CSF that is not easily isolated by complex sugar chain interference. The present invention relates to a method for effectively removing amylase produced by the system by hydrophobic chromatography and ammonium sulfate elution combination, wherein the rice cell-derived hGM-CSF is isolated and purified purely from rice cell liquid suspension culture according to the present invention. can do.

벼 세포 유래 hGM-CSF는 벼 세포 액체 현탁 배양 시 당 고갈에 의한 알파 아밀라제 프로모터에 작동에 의하여 발현되어 배양액으로 분비된다. 배양이 종료되면 액체 현탁 배양액 내의 벼 세포를 필터를 사용하여 제거한다. 벼 세포 유래 hGM-CSF는 비 균일하지만 평균분자량이 25 kDa 정도 되기 때문에 hGM-CSF를 농축하기 위해 10 KDa UF 멤브레인을 사용한다. Pre-filter로 배양액을 필터하고 10 KDa UF 멤브레인을 사용하여 액 부피를 1/10로 농축하고 탈염 후, 사전에 완충용액으로 평형화 시킨 DEAE 음이온 교환 크로마토그래피에 로딩 한다. Rice cell-derived hGM-CSF is expressed by acting on the alpha amylase promoter by sugar depletion in rice cell liquid suspension culture and secreted into the culture. At the end of the incubation, the rice cells in the liquid suspension culture are removed using a filter. Since rice cell-derived hGM-CSF is non-uniform but has an average molecular weight of about 25 kDa, a 10 KDa UF membrane is used to concentrate the hGM-CSF. Filter the cultures with pre-filter, concentrate the solution volume to 1/10 using a 10 KDa UF membrane, desalting and load into DEAE anion exchange chromatography previously equilibrated with buffer.

벼 세포 유래 hGM-CSF는 등전점이 산성 pH에 존재하기 때문에 농축 탈염된 hGM-CSF는 중성 이상의 pH 조건에서 DEAE 음이온 교환 크로마토그래피에 잘 흡착된다. 벼 세포 유래 hGM-CSF는 pH 8.5 완충용액에서 가장 잘 흡착되었고, pH 6.5에서는 흡착율이 다소 저하된 반면 pH 7.5에서는 hGM-CSF와 불순단백질의 분리도가 가장 좋았기 때문에 DEAE 음이온 교환 크로마토그래피 작업은 pH 7.5에서 이루어졌다. DEAE 음이온 교환 크로마토그래피에 흡착된 벼 세포 유래 hGM-CSF는 50, 100, 150, 200, 250 mM NaCl 농도 구배를 가하여 용출시켰다. SDS-PAGE 확인결과 20 mM 포스페이트 완충용액 (pH 7.5)과 100 mM NaCl 농도구배에서 벼 세포 유래 hGM-CSF의 용출이 이루어 졌으며, 벼 세포 액체 현탁 배양액의 많은 불순물들이 분리 제거되었다 (도 1).Since rice cell-derived hGM-CSF has an isoelectric point at an acidic pH, concentrated desalted hGM-CSF is well adsorbed on DEAE anion exchange chromatography at neutral or higher pH conditions. The rice-derived hGM-CSF was best adsorbed in pH 8.5 buffer, the adsorption rate was slightly lowered at pH 6.5, while the separation of hGM-CSF and impure protein was the best at pH 7.5. At 7.5. Rice cell-derived hGM-CSF adsorbed on DEAE anion exchange chromatography was eluted by adding gradients of 50, 100, 150, 200, and 250 mM NaCl. SDS-PAGE confirmed the elution of rice cell-derived hGM-CSF in 20 mM phosphate buffer (pH 7.5) and 100 mM NaCl concentration gradient, many impurities in the rice cell liquid suspension culture was removed and removed (Fig. 1).

그러나 벼 세포 유전자 발현 프로모터 시스템에 의해 생성되는 아밀라제 (Amylase)는 상기 조건의 DEAE 음이온 교환 크로마토그래피 방법으로 잘 제거되지 않았다. 따라서, 상기 아밀라제를 벼 세포 유래 hGM-CSF로부터 효과적으로 제거하기 위하여 젤 여과 크로마토그래피를 적용하여 보았으나 아밀라제는 분자량이 벼 세포 유래 hGM-CSF보다 상당히 큼에도 불구하고 전혀 분리되지 않았다. 이는 아밀라제가 hGM-CSF의 당쇄에 흡착되거나 hGM-CSF와 물리적으로 결합되어 용해된 때문으로 판단되었다. However, amylase produced by the rice cell gene expression promoter system was not well removed by DEAE anion exchange chromatography method under these conditions. Thus, gel filtration chromatography was applied to effectively remove amylase from rice cell-derived hGM-CSF, but amylase was not isolated at all despite its significantly higher molecular weight than rice cell-derived hGM-CSF. This was judged to be due to amylase adsorbed to sugar chains of hGM-CSF or dissolved physically with hGM-CSF.

젤 여과 크로마토그래피에서 분리가 잘되지 않는 아밀라제를 효과적으로 제거하기 위하여 마그네틱 교반기에서 1 M HCl을 가하여 pH를 서서히 5.0으로 조정하면 침전물이 발생하는데 본 과정에서 아밀라제가 상당부분 hGM-CSF로부터 제거된다 (도 2). 또한, 제거가 용이하지 않은 hGM-CSF 주변의 분자량을 갖는 불순물 단백질들을 효과적으로 제거하기 위하여 소수성 크로마토그래피를 적용하여 보았다. 벼 세포 유래 hGM-CSF가 함유된 DEAE 음이온 교환 크로마토그래피 용출액의 pH를 7.0으로 조정하고 NaCl을 첨가하여 2 M NaCl 및 2.5 M NaCl로 염 농도를 조절한 후 각각 소수성 페닐 세파로즈 그로마토그래피에 hGM-CSF를 흡착시켰다. 그 후 NaCl 염 농도를 하강시켜 hGM-CSF를 용출시켜 보았는데, NaCl 염 사용 시 소수성 페닐 세파 로즈 hGM-CSF의 흡착이 잘 되지 못하였으며, 용출 시에도 hGM-CSF의 분리도가 그렇게 좋지 못하였다 (도 6 및 도 7). To effectively remove amylase, which is difficult to separate in gel filtration chromatography, the pH is gradually adjusted to 5.0 by adding 1 M HCl in a magnetic stirrer to precipitate. In this process, amylase is substantially removed from hGM-CSF (Fig. 2). In addition, hydrophobic chromatography was applied to effectively remove impurity proteins having a molecular weight around hGM-CSF which is not easy to remove. The pH of the DEAE anion exchange chromatography eluate containing hGM-CSF derived from rice cells was adjusted to 7.0 and the salt concentration was adjusted to 2 M NaCl and 2.5 M NaCl by addition of NaCl, followed by hGM on hydrophobic phenyl sepharose chromography. -CSF was adsorbed. Thereafter, the concentration of NaCl was lowered to elute the hGM-CSF, but the adsorption of the hydrophobic phenyl sepharose hGM-CSF was not good when the NaCl salt was used, and the separation of the hGM-CSF was not so good even when the elution was performed. 6 and FIG. 7).

이에 본 발명자들은 여러 다른 염들을 시도해 본 결과 황산암모늄염 ((NH4)2SO4)을 사용할 때 벼 세포 유래의 당쇄가 과량 부착된 hGM-CSF가 흡착도 잘될 뿐만 아니라 용출 시에도 hGM-CSF가 높은 순도로 용출됨을 발견하여 본 발명을 완성할 수 있었다. 이를 좀 더 구체적으로 설명하면 다음과 같다. 황산암모늄염으로 DEAE 음이온 교환 크로마토그래피 용출액의 염 농도를 1.5 M까지 조절한 후 소수성 페닐 세파로즈 그로마토그래피에 hGM-CSF를 흡착하고 황산암모늄염 농도를 하향 구배 (1.2 M, 0.9 M, 0.6 M, 0.3 M, 0 M 순서로 구배시킴)로 진행하여 hGM-CSF를 용출시킨다. 용출 분획을 SDS-PAGE로 분석해 보면 hGM-CSF는 1.2 M, 0.9 M, 0.6 M 황산암모늄염에서 용출됨이 확인되는데 순도가 가장 높은 hGM-CSF의 용출은 0.9 M 황산암모늄염에서 이루어진다 (도 3). 0.9 M의 황산암모늄염은 10 KDa Molecular Cut-off UF 농축기를 사용하여 Diafiltration 법으로 손쉽게 제거할 수 있으며, 염 제거가 끝난 용액은 PBS 완충용액으로 최종 치환한다.Therefore, the present inventors have tried different salts. As a result, when using ammonium sulfate salt ((NH 4 ) 2 SO 4 ), hGM-CSF having an excess sugar chain derived from rice cells was well adsorbed, and the hGM-CSF was released even when eluted. The present invention was completed by discovering high eluting. If this is explained in more detail as follows. Adjust the salt concentration of the DEAE anion exchange chromatography eluate with ammonium sulphate to 1.5 M, and then adsorb the hGM-CSF to the hydrophobic phenyl sepharose chromatography and lower the concentration of ammonium sulphate (1.2 M, 0.9 M, 0.6 M, 0.3 M, gradient to 0 M sequence) to elute hGM-CSF. Analysis of the elution fraction by SDS-PAGE confirms that the hGM-CSF is eluted in 1.2 M, 0.9 M, and 0.6 M ammonium sulfate. The highest purity of the hGM-CSF is eluted in 0.9 M ammonium sulfate (FIG. 3). Ammonium sulfate of 0.9 M can be easily removed by Diafiltration using a 10 KDa Molecular Cut-off UF concentrator. The salt-removed solution is finally substituted with PBS buffer.

이상 설명한 바와 같이, 소수성 크로마토그래피와 황산암모늄염의 조합 사용이 벼 세포 유래 당쇄가 비균일하게 다량 부착된 hGM-CSF의 분리 정제에 매우 효과적임을 알 수 있다. 상기 핵심 공정을 통해 벼 세포 유래의 당쇄에 의한 전형적인 hGM-CSF의 패턴을 얻을 수 있으며, hGM-CSF 주변의 불순물 밴드나 상부의 Amylase 불순물 밴드들을 매우 효과적으로 제거할 수 있다. 이렇게 순수 분리 정제된 벼 세포 유래 hGM-CSF는 hGM-CSF 국제 표준품과 역가 비교 시 생물학적 활성이 매우 우수하였다. As described above, it can be seen that the combined use of hydrophobic chromatography and ammonium sulfate salt is very effective for the separation and purification of hGM-CSF to which the sugar cell-derived sugar chains are non-uniformly attached. Through this core process, a pattern of a typical hGM-CSF by sugar chains derived from rice cells can be obtained, and the impurity bands around the hGM-CSF or the Amylase impurity bands above can be removed very effectively. The purely purified rice cell-derived hGM-CSF showed excellent biological activity when compared to the titer of hGM-CSF international standard.

NaCl 염을 사용 시에는 소수성 크로마토그래피가 이러한 분리능을 보여주지 못하는 것을 살펴볼 때 본 발명자들이 발견한 소수성 크로마토그래피와 황산암모늄염의 조합 사용은 매우 특이하다고 할 수 있으며 식물 유래 다른 당 단백질들을 분리 정제 시에도 매우 효과적일 것이라 예상된다.The use of a combination of hydrophobic chromatography and ammonium sulphate found by the inventors of the present invention is very specific when the hydrophobic chromatography does not show such resolution when NaCl salt is used. It is expected to be very effective.

본 발명은 기재된 구체 예를 중심으로 상세히 설명되었지만, 본 발명의 범주 및 기술사상 범위 내에서 다양한 변형 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구 범위에 속하는 것도 당연한 것이다.While the invention has been described in detail with reference to the described embodiments, it will be apparent to those skilled in the art that various modifications and variations are possible within the scope and spirit of the invention, and such variations and modifications are within the scope of the appended claims. will be.

(실시 예 1) 벼 세포 유래 hGM-CSF를 함유한 세포 현탁 배양액의 전처리Example 1 Pretreatment of Cell Suspension Culture Solution Containing Rice Cell-derived hGM-CSF

벼 세포 현탁 배양액 20 L를 필터를 이용하여 세포와 배양액을 분리하였다. 프리필터에 의해 1차 걸러진 배양액을 0.45 마이크로 캡슐 필터를 사용하여 2차 필터를 하였으며, 필터 되어진 배양액을 Millipore 10 KDa Molecular Cut-off UF 농축기 (멤브레인 면적 0.5M2)를 사용하여 통과되는 배양액은 버리고 액을 농축하여 1 L로 부피를 줄였다. 배지성분과 염을 확실히 제거하고 DEAE 이온교환수지에 흡착시키기 위하여 20 mM Phosphate 완충액 (pH7.5)으로 부피가 총 2 L가 되도록 희석한 후 UF 농축 희석을 약 10회 반복하였다. 이 후 비이커에 농축된 1 L를 옮긴 후 Phosphate 완충액으로 UF 멤브레인을 세척하여 총 1.5 L 용액을 회수하였다.20 L of rice cell suspension culture was used to filter the cells and the culture. The culture medium filtered by the pre-filter was secondary filter using a 0.45 microcapsule filter, and the culture medium passed through the filtered culture medium using a Millipore 10 KDa Molecular Cut-off UF concentrator (membrane area 0.5M 2 ) was discarded. The solution was concentrated to 1 L of volume. After diluting the media components and salts and adsorbing the DEAE ion exchange resin to a total volume of 2 L with 20 mM Phosphate buffer (pH7.5), UF concentration dilution was repeated about 10 times. Thereafter, 1 L of the concentrated solution was transferred to a beaker, and the UF membrane was washed with Phosphate buffer to recover a total of 1.5 L solution.

회수액은 500 mL 원심분리 용기에 약 300 mL 씩 담아 15,000g로 30 분간 원심분리를 실시하고 와트만 거름종이4에 원심 분리된 용액을 여과한 후 비이커에 이를 모아 다음 스텝에서 사용할 때까지 냉장 보관하였다.The collected solution was placed in a 500 mL centrifuge container, about 300 mL, centrifuged at 15,000 g for 30 minutes, and the solution was centrifuged in Whatman filter paper 4, collected in a beaker, and refrigerated until use in the next step. .

(실시 예 2) 음이온교환수지를 이용한 벼 세포 유래 hGM-CSF의 회수 정제 Example 2 Recovery and Purification of Rice Cell-derived hGM-CSF Using Anion Exchange Resin

B&B사 BPG100/500 컬럼에 DEAE 세파로즈 음이온교환수지를 500 mL 패킹하고, 20 mM Phosphate 완충액 (pH7.5)을 100 mL/min에 유속으로 흘려 평형화하였다, 냉장 보관된 hGM-CSF 함유 용액을 100 mL/min 유속으로 음이온교환수지에 흡착시키고, 평형화 왼충용액을 로딩하였다. 평형화 완충용액에 NaCl 농도가 50 mM, 100 mM, 150 mM, 200 mM, 250 mM이 되도록 용액을 제조하여, 낮은 염 농도로부터 높은 염 농도로 hGM-CSF를 용출시켜 여러 개의 1 L 용기에 분획하였다. 분획된 용출액은 15% SDS-PAGE로 hGM-CSF의 함유여부와 순도를 확인하였다 (도 1). 100 mM NaCl 분획에서 hGM-CSF가 확인되었다.500 mL of DEAE Sepharose anion exchange resin was packed into B & B BPG100 / 500 column, and 20 mM Phosphate buffer (pH7.5) was equilibrated by flowing the flow at 100 mL / min, and the refrigerated solution containing hGM-CSF was 100 Adsorption was carried out on the anion exchange resin at a mL / min flow rate, and the equilibrium left buffer solution was loaded. Solutions were prepared in equilibration buffers with NaCl concentrations of 50 mM, 100 mM, 150 mM, 200 mM, 250 mM, eluted hGM-CSF from low salt concentration to high salt concentration and fractionated into several 1 L vessels. . The fractionated eluate was checked for the presence and purity of hGM-CSF by 15% SDS-PAGE (Fig. 1). HGM-CSF was identified in the 100 mM NaCl fraction.

(실시 예 3) 산 처리에 의한 불순물 제거Example 3 Impurity Removal by Acid Treatment

실시 예 2의 DEAE 세파로즈 음이온교환수지로 부터 용출된 100 mM NaCl 분획 용액을 10 KDa Molecular Cut-off UF 농축기 (Millipore Lab Scale TFF System)로 회수 농축하여 부피를 200 mL로 줄이고, 비이커에 회수한 후 마그네틱 교반기에서 1 M HCl을 가하여 pH를 서서히 5.0으로 조정한다. 이때 침전물이 발생하는데 이를 제거하기 위하여 500 mL 원심분리 용기에 200 mL 담아 15,000g로 30분간 원심분리를 실시하고 와트만 거름종이4로 여과하였다. 여과된 용액을 마그네틱 교반기에서 교반하면서 1 M NaOH로 pH를 서서히 7.0으로 올린 후 1.5 M 황산암모늄염 (pH 7.0)으로 조정하였다. 본 공정에서는 아밀라제 불순물을 상당히 효과적으로 줄일 수 있다 (도 2).The 100 mM NaCl fraction solution eluted from the DEAE Sepharose anion exchange resin of Example 2 was recovered and concentrated by a 10 KDa Molecular Cut-off UF concentrator (Millipore Lab Scale TFF System) to reduce the volume to 200 mL and recovered in a beaker. The pH is then slowly adjusted to 5.0 by adding 1 M HCl in a magnetic stirrer. At this time, precipitates were generated. In order to remove them, 200 mL was placed in a 500 mL centrifuge container and centrifuged at 15,000 g for 30 minutes, and filtered with Whatman filter paper 4. The filtered solution was slowly raised to 7.0 with 1 M NaOH while stirring in a magnetic stirrer and then adjusted to 1.5 M ammonium sulfate (pH 7.0). In this process, amylase impurities can be significantly reduced (FIG. 2).

(실시 예 4) 소수성 크로마토그래피와 황산암모늄염 조합에 의한 벼 세포 유래 hGM-CSF의 순도 향상 Example 4 Purity of Rice Cell-derived hGM-CSF by Hydrophobic Chromatography and Ammonium Sulfate Combination

소수성 페닐 세파로즈를 B&B사의 XK50 컬럼에 50 mL 패킹하고 1.5 M 황산암모늄염이 함유된 20 mM Phosphate 완충용액 (pH 7.0)을 사용하여 20 mL/min 유속으로 평형화시켰다. 이후 실시 예 3의 여과액을 소수성 페닐 세파로즈에 통과시켜 hGM-CSF를 흡착시키고 1.5 M 황산암모늄염이 함유된 20 mM Phosphate 완충용액 (pH 7.0)으로 소수성 페닐 세파로즈를 세척한 후, 1.2 M, 0.9 M, 0.6 M, 0.3 M, 0 M 구배로 황산암모늄염 용액을 소수성 페닐 세파로즈에 가하여 hGM-CSF를 용출시켰다. 용출 분획은 농도별로 50 mL 플라스틱 용기에 각 황산암모늄염 농도별로 10 개 씩 나누어 받았다. 분획된 용출액은 분석 전까지 냉장 보관 했으며, 15% SDS-PAGE로 hGM-CSF의 함유여부와 순도를 확인하였다 (도 4).Hydrophobic phenyl sepharose was packed into 50 mL of B & B's XK50 column and equilibrated at 20 mL / min flow rate using 20 mM Phosphate buffer (pH 7.0) containing 1.5 M ammonium sulfate. The filtrate of Example 3 was then passed through hydrophobic phenyl sepharose to adsorb hGM-CSF and washed with hydrophobic phenyl sepharose with 20 mM Phosphate buffer (pH 7.0) containing 1.5 M ammonium sulfate, followed by 1.2 M, Ammonium sulfate solution was added to hydrophobic phenyl sepharose in a 0.9 M, 0.6 M, 0.3 M, 0 M gradient to elute hGM-CSF. The elution fractions were divided into 10 mL for each ammonium sulfate concentration in 50 mL plastic containers by concentration. The fractionated eluate was refrigerated until analysis, and the content and purity of hGM-CSF were confirmed by 15% SDS-PAGE (FIG. 4).

(실시 예 5) 황산암모늄염의 제거Example 5 Removal of Ammonium Sulfate

15% SDS-PAGE 확인 결과 소수성 페닐 세파로즈에서 용출된 50 mL의 분획 중에 0.9 M 황산암모늄염 용출 용액 1 ~ 10 번과 0.6 M 황산암모늄염 용출 용액 1 ~ 3 번의 순도가 가장 높은 것으로 확인되었다 (도 4). 이를 모아서 10 KDa Molecular Cut-off UF 농축기를 이용하여 Dialfiltration 법으로 황산암모늄염을 제거한 후 PBS 완충용액으로 바꾸어 주고 0.2 um 필터로 최종 제균 처리하여 생물의약품 원제로 사용할 수 있는 최종 농축 원액을 제조하였다. 15% SDS-PAGE confirmed that the highest purity of 0.9 M ammonium sulphate eluting solution 1 to 10 and 0.6 M ammonium sulphate eluting solution 1 to 3 was obtained in 50 mL fractions eluted from hydrophobic phenyl sepharose (FIG. 4). ). After collecting the ammonium sulfate by dialfiltration method using a 10 KDa Molecular Cut-off UF concentrator, the resultant solution was converted into PBS buffer solution and finally sterilized by a 0.2 um filter to prepare a final concentrated stock solution that can be used as a biopharmaceutical raw material.

농축 원액의 순도를 확인하기 위하여 10배 20배 희석액을 15% SDS-PAGE로 분리 후 Silver Staining으로 염색하여 관찰한 결과 벼 세포 유래의 당쇄에 의한 전형적인 hGM-CSF의 패턴이 나타났으며 주변의 불순물 밴드나 상부의 Amylase 불순물 밴드를 전혀 관찰 할 수 없었다 (도 5). 따라서 소수성 크로마토그래피와 황산암모늄염의 조합 사용이 벼 세포 유래 당쇄가 다량 비균일하게 부착된 hGM-CSF의 분리 정제에 매우 효과적임을 알 수 있다.To confirm the purity of the concentrated stock solution, 10-fold and 20-fold dilutions were separated by 15% SDS-PAGE and stained with Silver Staining. As a result, a typical pattern of hGM-CSF due to sugar chains derived from rice cells was observed. No band or upper Amylase impurity band could be observed at all (FIG. 5). Therefore, it can be seen that the combined use of hydrophobic chromatography and ammonium sulfate salt is very effective for the separation and purification of hGM-CSF to which the sugar cell-derived sugar chains are attached in a large amount.

도 1은 DEAE 이온교환 크로마토그래피 분리 정제 과정의 SDS-PAGE 확인 결과를 나타낸 도면이다.1 is a view showing the results of SDS-PAGE verification of the DEAE ion exchange chromatography separation purification process.

도 2는 산 처리에 의한 Amylase 불순물 제거 효과의 SDS-PAGE 확인 결과 도면이다.2 is a SDS-PAGE confirming result of the effect of removing Amylase impurities by acid treatment.

도 3은 소수성 페닐 세파로즈 크로마토그래피와 황산암모늄염의 조합에 의한 hGM-CSF 분리 정제 효과의 SDS-PAGE 확인 도면이다.FIG. 3 is an SDS-PAGE confirming diagram of hGM-CSF separation and purification effect by a combination of hydrophobic phenyl sepharose chromatography and ammonium sulfate. FIG.

도 4는 소수성 페닐 세파로즈 크로마토그래피 분리 정제 과정에서 황산암모늄염 농도구배 (0.9 M - 0.6 M)의 SDS-PAGE 확인 결과 도면이다.4 is a SDS-PAGE confirming result of ammonium sulfate concentration gradient (0.9 M-0.6 M) during hydrophobic phenyl sepharose chromatography separation and purification process.

도 5는 Diafiltration에 의한 황산암모늄염 제거 후 hGM-CSF 최종 농축액의 순도 확인 결과 도면이다.5 is a diagram showing the purity of the final concentration of hGM-CSF after removal of ammonium sulfate by Diafiltration.

도 6은 소수성 페닐 세파로즈 크로마토그래피와 2 M NaCl 조합에 의한 hGM-CSF 분리 정제 과정의 SDS-PAGE 확인 결과 도면이다.FIG. 6 is a diagram showing the results of SDS-PAGE identification of hGM-CSF separation and purification by hydrophobic phenyl sepharose chromatography and 2M NaCl.

도 7은 소수성 페닐 세파로즈 크로마토그래피와 2.5 M NaCl 조합에 의한 hGM-CSF 분리 정제 과정의 SDS-PAGE 확인 결과 도면이다.7 is a SDS-PAGE confirming result of the purification process of hGM-CSF separation by hydrophobic phenyl sepharose chromatography and 2.5 M NaCl combination.

Claims (3)

소수성 크로마토그래피와 황산암모늄염을 조합 사용하여 벼 세포 액체 현탁 배양액 또는 전 처리된 액으로부터 재조합 인체 과립구 대식세포 콜로니 자극인자 hGM-CSF를 순수하게 분리 정제하는 방법.A method for purely separating and purifying recombinant human granulocyte macrophage colony stimulator hGM-CSF from rice cell liquid suspension culture or pretreated solution using a combination of hydrophobic chromatography and ammonium sulfate. 상기 제 1항에 있어서, 소수성 크로마토그래피는 페닐 세파로즈 (Phenyl Sepharose)임을 특징으로 하는 방법.The method of claim 1, wherein the hydrophobic chromatography is phenyl Sepharose (Phenyl Sepharose). 상기 제 1항에 있어서 소수성 크로마토그래피의 적용 염 농도 조건은 황산암모늄염 1.2 M 이상이며, hGM-CSF 용출 염 농도 조건은 황산암모늄 염 1.2 M 내지 0.6 M 사이 임을 특징으로 하는 방법.The method according to claim 1, wherein the applied salt concentration condition of hydrophobic chromatography is at least 1.2 M ammonium sulfate, and the eluted salt concentration condition of hGM-CSF is between 1.2 M and 0.6 M ammonium sulfate salt.
KR1020070075434A 2007-07-27 2007-07-27 Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa KR20070091081A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070075434A KR20070091081A (en) 2007-07-27 2007-07-27 Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070075434A KR20070091081A (en) 2007-07-27 2007-07-27 Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa

Publications (1)

Publication Number Publication Date
KR20070091081A true KR20070091081A (en) 2007-09-07

Family

ID=38689136

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070075434A KR20070091081A (en) 2007-07-27 2007-07-27 Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa

Country Status (1)

Country Link
KR (1) KR20070091081A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891429A (en) * 1984-07-06 1999-04-06 The Novartis Corporation Recombinant human granulocyte-macrophage-colony stimulating factor (GM-CSF)
KR100212071B1 (en) * 1994-10-08 1999-08-02 유충식 Method of purification of active human granulocyte colony stimulating factor
KR100254829B1 (en) * 1994-12-24 2000-05-01 성재갑 Improved purification method of recombinant human gm-csf

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891429A (en) * 1984-07-06 1999-04-06 The Novartis Corporation Recombinant human granulocyte-macrophage-colony stimulating factor (GM-CSF)
KR100212071B1 (en) * 1994-10-08 1999-08-02 유충식 Method of purification of active human granulocyte colony stimulating factor
KR100254829B1 (en) * 1994-12-24 2000-05-01 성재갑 Improved purification method of recombinant human gm-csf

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
논문1:한국생물공학회 *
논문2:Blood *

Similar Documents

Publication Publication Date Title
US10428107B2 (en) Method for isolating and purifying recombinant human serum albumin from transgenic rice grain
US10981975B2 (en) Method for efficient purification of human serum albumin
US5346992A (en) Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction
JP2017526649A (en) New process for purification of rHu-GCSF
KR101443257B1 (en) Methods for Purifying Erythropoietin Analogs Having Lower Isoelectric Point
US20110152506A1 (en) Method for Purifying Erythropoietin
US4751078A (en) Process for the purification of gamma interferon
KR102154952B1 (en) Non-Protein A Purification of Adalimumab
US10723775B2 (en) Method for purifying darbepoetin alfa
CN113121637A (en) Separation and purification method of recombinant protein
WO2011156369A2 (en) Purification of modified cytokines
KR20070091081A (en) Method for purifying human granulocyte microphage colony stimulating factor from the suspension culture broth of oryza sativa
JP7445332B2 (en) Optimized method for bevacizumab purification
US6869934B2 (en) Method of purifying calcium ion-binding protein
CN103570828B (en) The purifying for the protease inhibitors of α 1 that cell culture obtains
CN114885608A (en) Method for purifying recombinant proteins
KR100531670B1 (en) Processes for preparing interferon alpha
JP5086093B2 (en) Purification of recombinant human factor XIII
KR100369582B1 (en) Purification method of recombinant alpha-interferon
KR100297927B1 (en) Method of Purifying Human Erythropoietin
JP4154743B2 (en) Method for purifying interleukin-6 receptor
KR0184776B1 (en) Method of purifying recombinant human granulocyte colony stimulating factor
DE3907492A1 (en) METHOD FOR INSULATING AND CLEANING HPSTI AND HPSTI VARIANTS

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application